Primary Cell Culture Market To Reach $11.59 Billion By 2030

Primary Cell Culture Market Growth & Trends

The global primary cell culture market size is expected to reach USD 11.59 billion by 2030, expanding at a CAGR of 13.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.

Moreover, the field of regenerative medicine aims to replace or repair damaged tissues and organs, and primary cell culture plays a vital role in developing and engineering functional tissues. Primary cells are used to create tissue constructs, organoids, and bioengineered implants that closely mimic the structure and function of native tissues. These advancements have significant implications for regenerative medicine therapies, including tissue transplantation, wound healing, and the treatment of degenerative diseases. For instance, in April 2023, Mount Sinai launched a new institute for regenerative medicine to foster novel discoveries and explore new therapies for life-threatening diseases. The growing interest in regenerative medicine and the potential to revolutionize healthcare have led to increased investment and research in primary cell culture, propelling the market’s growth.

The COVID-19 pandemic has significantly impacted the primary cell culture industry. While the pandemic disrupted various industries, including healthcare and research, it highlighted the crucial role of primary cell culture in understanding viruses and developing treatments. Primary cells have been instrumental in studying the mechanisms of SARS-CoV-2 infection, testing antiviral therapies, and evaluating vaccine efficacy. The pandemic has accelerated the demand for primary cell culture products and services as researchers worldwide focused on COVID-19-related studies.

Furthermore, several developments undertaken by key market participants, and increasing industry-academia collaborations are driving the global market. For instance, in January 2023, Bio-Trac and ATCC collaborated to conduct a training workshop to offer an overview of the principles of primary cell culture, organoids and spheroids, and other related cell culture techniques.

 Request a free sample copy or view report summary: Primary Cell Culture Market Report

Primary Cell Culture Market Report Highlights

• By product, the reagent and supplements segment dominated with a share of 37.7% in 2023, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications

• By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2023, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation

• By cell type, the animal cells segment dominated the market with a share of 59.41% in 2022. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type

• North America established a strong regional position in the global market with a 41.52% share in 2023 due to its highly developed healthcare infrastructure and favorable government policies
  

Primary Cell Culture Market Segmentation

Grand View Research has segmented the global primary cell culture market on the basis of product, separation method, cell type, application and region:

Primary Cell Culture Product Outlook (Revenue, USD Million, 2018 - 2030)

• Primary Cells

  • Fat

  • Blood

  • Nerve

  • Bone

  • Endothelial

  • Skin

  • Muscle

  • Stem

  • Others

• Reagents and Supplements

  • Attachment Solution

  • Buffers and salts

  • Freezing Media

  • Sera

  • Growth factors and cytokines

• Media

  • Fat cells media

  • Blood cells media

  • Nerve cells media

  • Bone cells media

  • Endothelial cells media

  • Skin cells media

  • Muscle cell media

  • Stem cells media

  • Others

Primary Cell Culture Separation Method Outlook (Revenue, USD Million, 2018 - 2030)

• Explant Method

• Enzymatic Degradation

  • Trypsin

  • Collagenase

  • Protease

  • Pronase

  • Dispase

  • Hyaluronidase

  • Neuraminidase

  • Elastase

  • DNase

  • Papain

  • Accutase

  • Others

• Mechanical Separation

• Others

Primary Cell Culture Cell Type Outlook (Revenue, USD Million, 2018 - 2030)

• Animal Cells

• Human Cells

Primary Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cell & Gene Therapy Development

• Vaccine Production

• Model System

• Virology

• Prenatal Diagnosis

• Others

Primary Cell Culture Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait 

List of Key Players in the Primary Cell Culture Market

• Thermo Fisher Scientific, Inc.

• Lonza

• Merck

• Corning Incorporated

• Danaher

• PromoCell GmbH

• ATCC

• FUJIFILM Irvine Scientific, Inc.

• Mattek

• Axol Bioscience Ltd.